Antimetastatic potentials of salvianolic acid A on oral squamous cell carcinoma by targeting MMP-2 and the c-Raf/MEK/ERK pathway

Chih Yuan Fang, Ching Zong Wu, Pei Ni Chen, Yu Chao Chang, Chun Yi Chuang, Chih Ting Lai, Shun Fa Yang, Lo Lin Tsai

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The metastasis of oral squamous cell carcinoma (OSCC) is one of the most important causes of cancer-related deaths. Thus, various therapeutic strategies have been developed to prevent the metastasis of OSCC. Salvianolic acid A (SAA), a traditional Chinese medicine, has antithrombosis, antiplatelet, anti-inflammation, and antitumor activities. Here, we provide molecular evidence indicating that SAA exerts its antimetastatic effects by markedly inhibiting the invasion and migration of oral squamous SCC-9 and SCC-25 cells. SCC-9 and SCC-25 cells were treated with various concentrations of SAA to further investigate the precise involvement of SAA in cancer metastasis. The results of zymography, and Western blotting indicated that SAA treatment may decrease matrix metallopoteinase-2 (MMP-2) expression. SAA also inhibited p-c-Raf, p-MEK1/2, and p-ERK1/2 protein expression. In addition, treating SCC-9 cells with U0126, a MEK-specific inhibitor, decreased MMP-2 expression and concomitantly inhibited cell migration. Our findings suggested that SAA inhibits the invasion and migration of OSCC by inhibiting the c-Raf/MEK/ERK pathways that control MMP-2 expression. Our findings provide new insights into the molecular mechanisms that underlie the antimetastatic effect of SAA and are thus valuable for the development of treatment strategies for metastatic OSCC.

Original languageEnglish
JournalEnvironmental Toxicology
DOIs
Publication statusAccepted/In press - Jan 1 2018

Fingerprint

MAP Kinase Signaling System
Mitogen-Activated Protein Kinase Kinases
targeting
Squamous Cell Carcinoma
matrix
acid
Neoplasm Metastasis
cancer
salvianolic acid A
Epithelial Cells
Chinese Traditional Medicine
medicine
Medicine
Cell Movement
inhibitor
Neoplasms
Therapeutics
Western Blotting
Inflammation
protein

Keywords

  • Invasion
  • Metastasis
  • MMP-2
  • Oral squamous cell carcinoma
  • Salvianolic acid A

ASJC Scopus subject areas

  • Toxicology
  • Management, Monitoring, Policy and Law
  • Health, Toxicology and Mutagenesis

Cite this

Antimetastatic potentials of salvianolic acid A on oral squamous cell carcinoma by targeting MMP-2 and the c-Raf/MEK/ERK pathway. / Fang, Chih Yuan; Wu, Ching Zong; Chen, Pei Ni; Chang, Yu Chao; Chuang, Chun Yi; Lai, Chih Ting; Yang, Shun Fa; Tsai, Lo Lin.

In: Environmental Toxicology, 01.01.2018.

Research output: Contribution to journalArticle

@article{2c362ff0451c4bbeb88003cf95176b66,
title = "Antimetastatic potentials of salvianolic acid A on oral squamous cell carcinoma by targeting MMP-2 and the c-Raf/MEK/ERK pathway",
abstract = "The metastasis of oral squamous cell carcinoma (OSCC) is one of the most important causes of cancer-related deaths. Thus, various therapeutic strategies have been developed to prevent the metastasis of OSCC. Salvianolic acid A (SAA), a traditional Chinese medicine, has antithrombosis, antiplatelet, anti-inflammation, and antitumor activities. Here, we provide molecular evidence indicating that SAA exerts its antimetastatic effects by markedly inhibiting the invasion and migration of oral squamous SCC-9 and SCC-25 cells. SCC-9 and SCC-25 cells were treated with various concentrations of SAA to further investigate the precise involvement of SAA in cancer metastasis. The results of zymography, and Western blotting indicated that SAA treatment may decrease matrix metallopoteinase-2 (MMP-2) expression. SAA also inhibited p-c-Raf, p-MEK1/2, and p-ERK1/2 protein expression. In addition, treating SCC-9 cells with U0126, a MEK-specific inhibitor, decreased MMP-2 expression and concomitantly inhibited cell migration. Our findings suggested that SAA inhibits the invasion and migration of OSCC by inhibiting the c-Raf/MEK/ERK pathways that control MMP-2 expression. Our findings provide new insights into the molecular mechanisms that underlie the antimetastatic effect of SAA and are thus valuable for the development of treatment strategies for metastatic OSCC.",
keywords = "Invasion, Metastasis, MMP-2, Oral squamous cell carcinoma, Salvianolic acid A",
author = "Fang, {Chih Yuan} and Wu, {Ching Zong} and Chen, {Pei Ni} and Chang, {Yu Chao} and Chuang, {Chun Yi} and Lai, {Chih Ting} and Yang, {Shun Fa} and Tsai, {Lo Lin}",
year = "2018",
month = "1",
day = "1",
doi = "10.1002/tox.22542",
language = "English",
journal = "Environmental Toxicology",
issn = "1520-4081",
publisher = "John Wiley and Sons Inc.",

}

TY - JOUR

T1 - Antimetastatic potentials of salvianolic acid A on oral squamous cell carcinoma by targeting MMP-2 and the c-Raf/MEK/ERK pathway

AU - Fang, Chih Yuan

AU - Wu, Ching Zong

AU - Chen, Pei Ni

AU - Chang, Yu Chao

AU - Chuang, Chun Yi

AU - Lai, Chih Ting

AU - Yang, Shun Fa

AU - Tsai, Lo Lin

PY - 2018/1/1

Y1 - 2018/1/1

N2 - The metastasis of oral squamous cell carcinoma (OSCC) is one of the most important causes of cancer-related deaths. Thus, various therapeutic strategies have been developed to prevent the metastasis of OSCC. Salvianolic acid A (SAA), a traditional Chinese medicine, has antithrombosis, antiplatelet, anti-inflammation, and antitumor activities. Here, we provide molecular evidence indicating that SAA exerts its antimetastatic effects by markedly inhibiting the invasion and migration of oral squamous SCC-9 and SCC-25 cells. SCC-9 and SCC-25 cells were treated with various concentrations of SAA to further investigate the precise involvement of SAA in cancer metastasis. The results of zymography, and Western blotting indicated that SAA treatment may decrease matrix metallopoteinase-2 (MMP-2) expression. SAA also inhibited p-c-Raf, p-MEK1/2, and p-ERK1/2 protein expression. In addition, treating SCC-9 cells with U0126, a MEK-specific inhibitor, decreased MMP-2 expression and concomitantly inhibited cell migration. Our findings suggested that SAA inhibits the invasion and migration of OSCC by inhibiting the c-Raf/MEK/ERK pathways that control MMP-2 expression. Our findings provide new insights into the molecular mechanisms that underlie the antimetastatic effect of SAA and are thus valuable for the development of treatment strategies for metastatic OSCC.

AB - The metastasis of oral squamous cell carcinoma (OSCC) is one of the most important causes of cancer-related deaths. Thus, various therapeutic strategies have been developed to prevent the metastasis of OSCC. Salvianolic acid A (SAA), a traditional Chinese medicine, has antithrombosis, antiplatelet, anti-inflammation, and antitumor activities. Here, we provide molecular evidence indicating that SAA exerts its antimetastatic effects by markedly inhibiting the invasion and migration of oral squamous SCC-9 and SCC-25 cells. SCC-9 and SCC-25 cells were treated with various concentrations of SAA to further investigate the precise involvement of SAA in cancer metastasis. The results of zymography, and Western blotting indicated that SAA treatment may decrease matrix metallopoteinase-2 (MMP-2) expression. SAA also inhibited p-c-Raf, p-MEK1/2, and p-ERK1/2 protein expression. In addition, treating SCC-9 cells with U0126, a MEK-specific inhibitor, decreased MMP-2 expression and concomitantly inhibited cell migration. Our findings suggested that SAA inhibits the invasion and migration of OSCC by inhibiting the c-Raf/MEK/ERK pathways that control MMP-2 expression. Our findings provide new insights into the molecular mechanisms that underlie the antimetastatic effect of SAA and are thus valuable for the development of treatment strategies for metastatic OSCC.

KW - Invasion

KW - Metastasis

KW - MMP-2

KW - Oral squamous cell carcinoma

KW - Salvianolic acid A

UR - http://www.scopus.com/inward/record.url?scp=85041231123&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041231123&partnerID=8YFLogxK

U2 - 10.1002/tox.22542

DO - 10.1002/tox.22542

M3 - Article

C2 - 29385302

AN - SCOPUS:85041231123

JO - Environmental Toxicology

JF - Environmental Toxicology

SN - 1520-4081

ER -